Why the study?
Does coronary artery calcium (CAC) testing effectively risk stratify asymptomatic individuals with diabetes to guide primary prevention therapies like aspirin?
Population
2,384 asymptomatic individuals with diabetes (from a larger cohort of 44,052 referred for CAC testing)
Design
Cohort
Follow-up
mean 5.6 ± 2.6 years
Authors
Loading...
May refine aspirin decisions in asymptomatic diabetes; leaves open whether CAC-guided therapy improves outcomes.
Does coronary artery calcium (CAC) testing effectively risk stratify asymptomatic individuals with diabetes to guide primary prevention therapies like aspirin?
CAC testing effectively risk stratifies asymptomatic patients with diabetes, potentially guiding primary prevention decisions such as low-dose aspirin use.
Silverman et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: